HT
MRTX

Headlands Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Headlands Technologies’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,449
Closed -$320K – 1611
2023
Q4 		$320K Buy
5,449
+4,926
+942% +$277K 0.1% 197
2023
Q3 		$22.8K Sell
523
-897
-63% -$32K 0.01% 574
2023
Q2 		$51.3K Buy
+1,420
New +$58.5K 0.02% 469

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Headlands Technologies's MRTX Position: Q1 2024 in Review

Headlands Technologies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 5,449 shares — an estimated $320K sold.

Headlands Technologies first reported a position in MRTX in Q2 2023 and held it in 3 quarters. The position peaked at $320K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Headlands Technologies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Headlands Technologies sold 5,449 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $320K.
  • Headlands Technologies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Headlands Technologies's Mirati Therapeutics, Inc. Common Stock position peaked at $320K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Headlands Technologies's 13F filing for Q1 2024, filed 7 May 2024.